Varduhi Ghazaryan

National Institute of Allergy and Infectious Diseases

Also affiliated with National Institutes of Health Clinical Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19”.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00384-2

N/A

4.4DataRank · unranked

167 citations

Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain +95 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00735-6

N/A

0.996DataRank · unranked

25 citations

Nadine Rouphael, Ruxana T. Sadikot, Maria C. Rodriguez‐Barradas, Micah T. McClain, Dana M Wilkins +32 more

Evaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01395-24

N/A

0.227DataRank · unranked

3 citations

Zhonghui Yang, Stephen P. Bergin, Robert M. Tighe, Emily Randolph, B. Hauser +7 more

Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad547

N/A

0DataRank · unranked

21 citations

David van Duin, Pranita D. Tamma, Thomas P. Lodise, Daria Van Tyne, Keith A. Rodvold +48 more

Daily fosfomycin versus levofloxacin for complicated urinary tract infections

mBio(2023)10.1128/mbio.01677-23

N/A

0DataRank · unranked

9 citations

Patricia Winokur, Michael C. Keefer, Jessica Traenkner, Ana Drobeniuc, Yohei Doi +39 more

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

Clinical Infectious Diseases(2023)10.1093/cid/ciad475

N/A

0DataRank · unranked

9 citations

H. R. Cross, Maria Souli, Scott Evans, Robin Patel, Vance G. Fowler +60 more

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

Clinical Infectious Diseases(2023)10.1093/cid/ciad565

N/A

0DataRank · unranked

6 citations

César A. Arias, Deena R. Altman, Ahmed Babiker, Helen W. Boucher, C. Buddy Creech +40 more

Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad541

N/A

0DataRank · unranked

5 citations

Ritu Banerjee, Sarah B. Doernberg, Scott Evans, Lauren Komarow, Michael J. Satlin +28 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598

Medical Mycology(2024)10.1093/mmy/myae032

N/A

0DataRank · unranked

11 citations

Robert W. Spitz, Erin Hammett, Anna Jaunarajs, Varduhi Ghazaryan, Edward P. Garvey +2 more

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients

Critical Care Explorations(2024)10.1097/cce.0000000000001159

N/A

0DataRank · unranked

3 citations

Omayma A. Kishk, Adnan Bhutta, Ginny E. Cummings, Hana M. El Sahly, Manpreet Virk +11 more

Staphylococcus simulans: A rare uropathogen

IDCases(2021)10.1016/j.idcr.2021.e01202

N/A

0DataRank · unranked

10 citations

Jessica Traenkner, Paulina A. Rebolledo, Varduhi Ghazaryan, Nadine Rouphael, Ana Drobeniuc